All Press Releases
PILA PHARMA UPCOMING INVESTOR PRESENTATIONS IN STOCKHOLM
Malmö, 10 June 2025 PILA PHARMA AB (publ) (FN STO: PILA), an innovative biotech company developing novel oral drugs based on TRPV1 inhibition for treatment of obesity and diabetes, hereby invites investors and others with interest in the space to these coming events: ___________10X Podcast (Online Recording - Stockholm, Sweden)Wednesday 11 June from 11:00 CETCEO Gustav H. Gram will participate…
PILA PHARMA DISCUSSED ITS POTENTIAL ROLE IN OBESITY & DIABETES WITH HELGE LARSEN & PROINVESTOR
Malmö, 10 June 2025 PILA PHARMA AB (publ) (FN STO: PILA) has the pleasure to share with investors and others with interest in the Company or the general market, that PILA PHARMA had a 1-on-1 interview with Helge Larsen from ProInvestor, conducted 05 June 2025.ProInvestor is Denmark's largest and one of the most sophisticated online forums uniting private and professional…
PILA PHARMA TO RE-VISIT PROINVESTOR WITH HELGE LARSEN TO DISCUSS THE COMPANY’S AMBITIONS IN OBESITY & DIABETES
Malmö, 04 June 2025 PILA PHARMA AB (publ) (FN STO: PILA) today informs investors and others with interest in the Company, that PILA PHARMA will be going back to participate for a 1-on-1 interview with Helge Larsen from ProInvestor, tomorrow 05 June 2025.ProInvestor is Denmark's largest and one of the most sophisticated online forums uniting private and professional investors with…